BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31067791)

  • 1. Relationship of Iron Metabolism and Short-Term Cuprizone Treatment of C57BL/6 Mice.
    Pandur E; Pap R; Varga E; Jánosa G; Komoly S; Fórizs J; Sipos K
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis Mediates Cuprizone-Induced Loss of Oligodendrocytes and Demyelination.
    Jhelum P; Santos-Nogueira E; Teo W; Haumont A; Lenoël I; Stys PK; David S
    J Neurosci; 2020 Nov; 40(48):9327-9341. PubMed ID: 33106352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cuprizone Administration Alters the Iron Metabolism in the Mouse Model of Multiple Sclerosis.
    Varga E; Pandur E; Abrahám H; Horváth A; Ács P; Komoly S; Miseta A; Sipos K
    Cell Mol Neurobiol; 2018 Jul; 38(5):1081-1097. PubMed ID: 29464444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
    Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
    Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CZ-7, a new derivative of Claulansine F, promotes remyelination induced by cuprizone by enhancing myelin debris clearance.
    Wang SS; Bi HZ; Chu SF; Dong YX; He WB; Tian YJ; Zang YD; Zhang DM; Zhang Z; Chen NH
    Brain Res Bull; 2020 Jun; 159():67-78. PubMed ID: 32289743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylcholine 36:1 concentration decreases along with demyelination in the cuprizone animal model and in post-mortem multiple sclerosis brain tissue.
    Trépanier MO; Hildebrand KD; Nyamoya SD; Amor S; Bazinet RP; Kipp M
    J Neurochem; 2018 Jun; 145(6):504-515. PubMed ID: 29574981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle.
    Taylor LC; Gilmore W; Ting JP; Matsushima GK
    J Neurosci Res; 2010 Feb; 88(2):391-402. PubMed ID: 19746424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of oligodendrocyte loss and mitochondrial toxicity in the cuprizone-induced experimental demyelination model.
    Acs P; Selak MA; Komoly S; Kalman B
    J Neuroimmunol; 2013 Sep; 262(1-2):128-31. PubMed ID: 23890807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of ellagic acid on cuprizone-induced acute demyelination through limitation of microgliosis, adjustment of CXCL12/IL-17/IL-11 axis and restriction of mature oligodendrocytes apoptosis.
    Sanadgol N; Golab F; Tashakkor Z; Taki N; Moradi Kouchi S; Mostafaie A; Mehdizadeh M; Abdollahi M; Taghizadeh G; Sharifzadeh M
    Pharm Biol; 2017 Dec; 55(1):1679-1687. PubMed ID: 28447514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional differences between grey and white matter in cuprizone induced demyelination.
    Gudi V; Moharregh-Khiabani D; Skripuletz T; Koutsoudaki PN; Kotsiari A; Skuljec J; Trebst C; Stangel M
    Brain Res; 2009 Aug; 1283():127-38. PubMed ID: 19524552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional heterogeneity of cuprizone-induced demyelination: topographical aspects of the midline of the corpus callosum.
    Schmidt T; Awad H; Slowik A; Beyer C; Kipp M; Clarner T
    J Mol Neurosci; 2013 Jan; 49(1):80-8. PubMed ID: 23054589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroids impair remyelination in the corpus callosum of cuprizone-treated mice.
    Clarner T; Parabucki A; Beyer C; Kipp M
    J Neuroendocrinol; 2011 Jul; 23(7):601-11. PubMed ID: 21507085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
    Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
    Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 17β-Estradiol enhances the efficacy of adipose-derived mesenchymal stem cells on remyelination in mouse model of multiple sclerosis.
    Ragerdi Kashani I; Hedayatpour A; Pasbakhsh P; Kafami L; Atlasi N; Pirhajati Mahabadi V; Mamoudi R; Baazm M
    Acta Med Iran; 2012; 50(12):789-97. PubMed ID: 23456519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Multiple Intraperitoneal Injections of Human Bone Marrow Mesenchymal Stem Cells on Cuprizone Model of Multiple Sclerosis.
    Marzban M; Mousavizadeh K; Bakhshayesh M; Vousooghi N; Vakilzadeh G; Torkaman-Boutorabi A
    Iran Biomed J; 2018 Sep; 22(5):312-21. PubMed ID: 29409311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of the stress-associated gene p8 in mouse models of demyelination and in multiple sclerosis tissues.
    Plant SR; Wang Y; Vasseur S; Thrash JC; McMahon EJ; Bergstralh DT; Arnett HA; Miller SD; Carson MJ; Iovanna JL; Ting JP
    Glia; 2006 Apr; 53(5):529-37. PubMed ID: 16374777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination.
    Tanaka T; Murakami K; Bando Y; Yoshida S
    J Neurochem; 2013 Oct; 127(2):259-70. PubMed ID: 23647102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected.
    Skripuletz T; Gudi V; Hackstette D; Stangel M
    Histol Histopathol; 2011 Dec; 26(12):1585-97. PubMed ID: 21972097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional regulation of glutamate signaling during cuprizone-induced demyelination in the brain.
    Azami Tameh A; Clarner T; Beyer C; Atlasi MA; Hassanzadeh G; Naderian H
    Ann Anat; 2013 Oct; 195(5):415-23. PubMed ID: 23711509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cuprizone-Containing Pellets Are Less Potent to Induce Consistent Demyelination in the Corpus Callosum of C57BL/6 Mice.
    Hochstrasser T; Exner GL; Nyamoya S; Schmitz C; Kipp M
    J Mol Neurosci; 2017 Apr; 61(4):617-624. PubMed ID: 28238065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.